Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Verkerk K., Geurts B.S., Zeverijn L.J., van der Noort V., Verheul HMW, Haanen JBAG, van der Veldt AAM, Eskens FALM, Aarts MJB, van Herpen CML et al., 2024/04. The Lancet regional health. Europe, 39 p. 100875. Peer-reviewed.
ici le détail